GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthorx Inc (NAS:THOR) » Definitions » Gross Profit

Synthorx (Synthorx) Gross Profit : $0.00 Mil (TTM As of Sep. 2019)


View and export this data going back to 2018. Start your Free Trial

What is Synthorx Gross Profit?

Synthorx's gross profit for the three months ended in Sep. 2019 was $0.00 Mil. Synthorx's gross profit for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Synthorx's gross profit for the three months ended in Sep. 2019 was $0.00 Mil. Synthorx's Revenue for the three months ended in Sep. 2019 was $0.00 Mil. Therefore, Synthorx's Gross Margin % for the quarter that ended in Sep. 2019 was N/A%.

Synthorx had a gross margin of N/A% for the quarter that ended in Sep. 2019 => No sustainable competitive advantage


Synthorx Gross Profit Historical Data

The historical data trend for Synthorx's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthorx Gross Profit Chart

Synthorx Annual Data
Trend Dec16 Dec17 Dec18
Gross Profit
- - -

Synthorx Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Gross Profit Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Synthorx's Gross Profit

For the Biotechnology subindustry, Synthorx's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthorx's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synthorx's Gross Profit distribution charts can be found below:

* The bar in red indicates where Synthorx's Gross Profit falls into.



Synthorx Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Synthorx's Gross Profit for the fiscal year that ended in Dec. 2018 is calculated as

Gross Profit (A: Dec. 2018 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Synthorx's Gross Profit for the quarter that ended in Sep. 2019 is calculated as

Gross Profit (Q: Sep. 2019 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Synthorx's Gross Margin % for the quarter that ended in Sep. 2019 is calculated as

Gross Margin % (Q: Sep. 2019 )=Gross Profit (Q: Sep. 2019 ) / Revenue (Q: Sep. 2019 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Synthorx  (NAS:THOR) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Synthorx had a gross margin of N/A% for the quarter that ended in Sep. 2019 => No sustainable competitive advantage


Synthorx Gross Profit Related Terms

Thank you for viewing the detailed overview of Synthorx's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthorx (Synthorx) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11099 North Torrey Pines Road, Suite 290, La Jolla, CA, USA, 92037
Executives
Powell Andrew Kenneth William director C/O COLLAGENEX PHARMACEUTICALS, INC., 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Ra Capital Healthcare Fund Lp 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p. 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky director, 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter A. Thompson director, 10 percent owner C/O ANTHERA PHARMACEUTICALS, INC., 25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD CA 94545
Vickie L Capps director 2985 SCOTT STREET, VISTA CA 92083
Rajeev M. Shah 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Jay Lichter director C/O ARATANA THERAPEUTICS, INC., 11400 TOMAHAWK CREEK PARKWAY, SUITE 340, LEAWOOD KS 66211
Laura Shawver director, officer: President and CEO 1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518
Avalon Ventures X, L.p. 10 percent owner 1134 KLINE STREET, LA JOLLA CA 92037
Orbimed Advisors Llc director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Capital Gp Vii Llc 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022